5/8
07:12 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
5/8
07:12 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
5/7
01:14 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
5/7
01:14 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
5/7
08:01 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $190.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $190.00 price target on the stock.
5/7
06:45 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
5/7
06:45 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
4/29
07:25 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $115.00 price target on the stock, up previously from $90.00.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $115.00 price target on the stock, up previously from $90.00.
4/29
07:25 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $115.00 price target on the stock, up previously from $90.00.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $115.00 price target on the stock, up previously from $90.00.
4/29
05:25 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
4/29
05:25 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
4/10
10:19 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
4/10
09:33 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
4/2
09:01 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $190.00 price target on the stock.
Medium
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $190.00 price target on the stock.
3/28
10:05 am
axsm
Rating for AXSM
Report
Rating for AXSM
3/28
10:05 am
axsm
Rating for AXSM
Report
Rating for AXSM
3/26
08:08 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/26
08:08 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/26
07:33 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/26
07:33 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/20
08:08 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.
3/19
08:10 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $108.00 price target on the stock.
Medium
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $108.00 price target on the stock.
3/19
04:46 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
3/19
04:46 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
3/4
08:06 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.
Medium
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.